Journal Guide

Crystallography Reviews publishes English language reviews of all aspects of crystallography. The main reviews are typically 20 to 80 pages long, with hundreds of references; and there are also book reviews. Topical reviews can be shorter (5000 words). The range of topics includes:- fundamentals of crystallography and applications in biology, chemistry, mathematics, physics and mineralogy as well as in industrial research; studies of the structural and symmetry aspects of solids, and includes small molecules and macromolecules as well as structural systematics and chemical design; methodological aspects include crystal growth, instrumentation and diffraction methods; and the interface of crystallography to other structure determination methods. The reviews are intended to be accessible to all scientists: not only crystallographers but also those working in related fields.Peer ReviewAll published research articles in Crystallography Reviews have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by expert reviewers.DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science.

The aim of this journal is to help readers understand expert views on current advances in the field of bladder dysfunction by systematically providing review articles that highlight the most important papers recently published.

We accomplish this aim by appointing major authorities in key subject areas across the discipline to select topics reviewed by leading experts who emphasize recent developments, novel research, and highlight important papers published over the past year on their topics. We also highlight areas that have not received attention in the past and are important to an international audience, such a voiding dysfunction in reconstructed bladders and voiding dysfunction associated with genitourinary infections. An Editorial Board of internationally diverse members also suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.

Current Chemical Biology aims to publish full-length and mini reviews as well as research papers on exciting new developments at the chemistry-biology interface, covering topics relating to Chemical Synthesis, Science at Chemistry-Biology Interface and Chemical Mechanisms of Biological Systems.

Current Enzyme Inhibition aims to publish original research, review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Current Metabolomics and Systems Biology publishes full-length/mini reviews, original research articles, thematic issues, and technical notes covering all aspects of the recent advancements and applications of Omics technology to systems biology, disease diagnosis, personalized medicine, drug discovery, toxicity, nutrition and food, environmental studies, and functional genomics. While the journal emphasis metabolomics, manuscripts describing the application of other Omics technology (e.g., genomics, proteomics, and transcriptomics), especially in combination with metabolomics, to systems biology are also welcome. This includes the application of Omics technology to clinical studies. Manuscripts appropriate for Current Metabolomics and Systems Biology should emphasize the application, development or enhancement of OMICS technology.

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Chemical Biology, we help the reader by providing in a systematic manner:1. The views of experts on current advances in chemical biology in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Division of the subject into sections:The subject of chemical biology is divided into themed sections which are reviewed regularly to keep them relevant. For 2014 they are:• Arrays • Bioinorganic chemistry • Biocatalysis and Biotransformation • Molecular Imaging • In Vivo Chemistry • Mechanisms • Synthetic Biology • Synthetic Biomolecules • Molecular ImmunologySelection of topics to be reviewed:Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Reviews:Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview:Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Chemical Biology one of the most highly regarded and highly cited review journals in the field.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Current Organic Synthesis publishes in-depth reviews, original research articles and letter/short communications on all areas of synthetic organic chemistry i.e. asymmetric synthesis, organometallic chemistry, novel synthetic approaches to complex organic molecules, carbohydrates, polymers, protein chemistry, DNA chemistry, supramolecular chemistry, molecular recognition and new synthetic methods in organic chemistry. The frontier reviews provide the current state of knowledge in these fields and are written by experts who are internationally known for their eminent research contributions. The journal is essential reading to all synthetic organic chemists. Current Organic Synthesis should prove to be of great interest to synthetic chemists in academia and industry who wish to keep abreast with recent developments in key fields of organic synthesis.

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Fundamental plant sciences is increasingly becoming a collaborative domain, with projects for example including physics, mathematics and chemistry. This is largely fuelled by the last decade's many technical advances, allowing for more discoveries but also creating new challenges, such as data storage, analysis and predictions. Interdisciplinary collaborations are often the solution to these challenges.

This journal aims to acknowledge and encourage interdisciplinary research in fundamental plant sciences. It will publish original research papers and method papers in plant research fields such as systems biology, cell biology, genetics, epigenetics, mathematical modeling, omics, signal transduction, plant-microbe interactions, synthetic biology, developmental biology, biochemistry, bioinformatics research, and big data in plant biology. High-quality review articles are also welcome.

To further encourage collaboration in the community, all accepted authors of Research articles are required to make their data accessible to the public. This will avoid duplicate projects and speed up the progress of science. The journal will actively link and cooperate with some of these databases, as well as with computational infrastructure. Data should always be submitted in raw data format, and should be submitted preferentially in publicly accessible resources maintained by for example EBI, EMBL, or NCBI data. Which data repository is used is up to the authors, however please visit http://www.elsevier.com/databaselinking for more information on depositing and linking your data with a supported data repository. For datatypes for which no such repositories exist, data should be made available through the supplementary information or the authors own website. If the data has been processed into e.g. pathways or models, then this should be made available also during the review process.

For more submission information, see our Guide for Authors.

The editorial and publishing team of the journal is dedicated to being efficient in the manuscript handling. The journal uses a double-blinded peer review, to avoid bias in the review process. The resulting publications will be open access.

Current Protein & Peptide Science publishes review articles on specific aspects involving proteins, peptides, and interactions between the enzymes, the binding interactions of hormones and their receptors; the properties of transcription factors and other molecules that regulate gene expression; the reactions leading to the immune response; the process of signal transduction; the structure and function of proteins involved in the cytoskeleton and molecular motors; the properties of membrane channels and transporters; and the generation and storage of metabolic energy. In addition, reviews of experimental studies of protein folding and design are given special emphasis. Manuscripts submitted to Current Protein and Peptide Science should cover a field by discussing research from the leading laboratories in a field and should pose questions for future studies. Original papers, research articles and letter articles/short communications are not considered for publication in Current Protein & Peptide Science.

Current Proteomics publishes in-depth/mini review articles in all aspects of the fast-expanding field of proteomics. All areas of proteomics are covered together with the methodology, software, databases, technological advances and applications of proteomics, including functional proteomics.